The largest database of trusted experimental protocols

D glucose 13c6

Manufactured by Merck Group
Sourced in United States, Germany

D-glucose-13C6 is a stable isotope-labeled compound that contains six carbon atoms, all of which are labeled with the carbon-13 isotope. It is a molecular entity used for various research and analytical applications, including metabolic studies, tracer experiments, and analytical techniques that require the use of labeled compounds.

Automatically generated - may contain errors

29 protocols using d glucose 13c6

1

Metabolic Analysis of Tat-Induced Changes in LUHMES Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
LUHMES were differentiated as described above. On the last day of differentiation, a glucose‐free medium with D‐Glucose‐13C6 (Aldrich, 389,374‐250MG) was added to the cells for 24 h. The cells were then treated with 100 ng/ml Tat or PBS for 8 h. Polar metabolites were extracted in ice‐cold 80% methanol. Mass spectrometry was conducted at the Proteomics and Metabolomics Center‐Wistar Institute, Philadelphia.27
+ Open protocol
+ Expand
2

Metabolic Profiling of LUHMES Cells Exposed to gp120

Check if the same lab product or an alternative is used in the 5 most similar protocols
LUHMES cells were cultured in a differentiation medium for 5 days. Then the medium was switched to a glucose-free differentiation medium with the addition of D-Glucose-13C6 (Aldrich, 389374-250MG) for an additional 24 h. Eight hours before collection, 100 ng/ml of recombinant gp120 protein were added to the cells. Control untreated cells were also cultured in an unlabeled differentiation medium lacking D-Glucose-13C6. The polar metabolites were collected using an ice-cold extraction solution of 80% methanol and 20% water. As previously described, samples were analyzed at the Proteomics and Metabolomics Center at the Wistar Institute in Philadelphia (Di Marcantonio et al., 2021 (link)). Raw data were normalized to total protein recovered from the polar metabolites and analyzed using MetaboAnalyst 5.0 online software1.
+ Open protocol
+ Expand
3

Inhibiting Glutamine Metabolism in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To inhibit glutamine dependent metabolic reactions, we applied two glutamine analogues namely 6-diazo-5-oxo-l-norleucine (DON) with a final concentration of 0.5 mmol/L and azaserine (both obtained from Sigma Aldrich) with a final concentration of 0.028 mmol/L to the incubation medium for 12 h. In our 15N labelling approach we used RPMI 1640 R7509 medium as incubation medium as described above but replaced unlabelled glutamine with 2 mmol/L of l-glutamine-(amide-15N) (obtained from Sigma Aldrich). For 13C labelling we used RPMI 1640 R1383 medium as incubation medium with 10% FCS, 2.0 g/L sodium bicarbonate and 11.0 mmol/L d-glucose-13C6 (obtained from Sigma Aldrich). For growth inhibition experiments cytochalasin D (Sigma Aldrich) was used in a final concentration of 1 μg/mL for 12 h.
+ Open protocol
+ Expand
4

Calibration Standards for Lipidomics

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Tuning Mix calibration standard from Agilent Technologies (Santa Clara, CA) was used. Sucrose-13C12, D-Glucose-13C6, and heavy water (2H2O) were purchased from Sigma-Aldrich (St. Louis, MO). A mixture of labelled lipid internal standards (EquiSplash Lipidomix) from Avanti Polar Lipids (Alabaster, AL) was used.
+ Open protocol
+ Expand
5

Stable Isotope Labeling of HEK293 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For 13C-glucose labelling, HEK293 cells were grown in glucose-free DMEM (Gibco) supplemented with 1 g/L d-Glucose-13C6 (Sigma), 10% FBS (Gibco), 2 mM l-Glutamine, 1% Pen/Strep 1 mM sodium pyruvate and non-essential amino acids. After 5 h of labelling, the medium was aspirated, the cells were placed on ice, washed twice with ice-cold PBS, scraped from the dish and transferred to the pre-cooled low-bind 1.5 mL tube. The cells were centrifuged for 3 min at 300 × g, 4 °C, and after removing the residual PBS immediately snap frozen in liquid nitrogen.
+ Open protocol
+ Expand
6

Metabolic Labeling of Yeast Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were inoculated into 5 ml of SD medium and were cultured at 25°C overnight. To enter the log-phase, an aliquot of precultured cells was resuspended in 10 ml of SD medium and were cultured at 25°C for 3 h. To incorporate 13C into cellular metabolites, 0.4% D-glucose-13C6 (Sigma-Aldrich, St. Louis, MO, USA) and 1.6% of natural D-glucose were used as carbon sources in the SD medium. The cells were harvested and suspended in 10 ml of SD medium containing 13C-glucose and were subsequently cultured at 25°C until an OD600 of 0.5 was reached.
+ Open protocol
+ Expand
7

Isotopic Labeling of P. aeruginosa

Check if the same lab product or an alternative is used in the 5 most similar protocols
P. aeruginosa PA14 was grown in M9 minimal media (2 mM MgSO4, 0.1 mM CaCl2, 0.4 % weight/volume (w/v) glucose, 47.9 mM Na2HPO4, 22 mM KH2PO4, 8.2 mM NaCl, 18.7 mM NH4Cl), with the only carbon source being d-glucose-13C6, (Sigma-Aldrich, Munich, Germany). To ensure all carbons were isotopically labeled (13C), cells were maintained in M9 minimal media containing 13C labeled glucose for at least two passages. P. aeruginosa was grown to OD600 ≥ 1.5 at 37 °C and cells were harvested by centrifugation and washed 1× with 0.9 % saline.
+ Open protocol
+ Expand
8

Isotopic Glucose Glycine Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The chemicals in this study included glycine (≥99.0%), sodium chloride (≥99.0%), D-glucose (≥99.0%), and o-phenylenediamine (OPD) (≥98.0%), which were purchased from Aladdin (Shanghai, China). In addition, D-glucose-13C6 (≥99.0%) was purchased from Sigma-Aldrich. Equal amounts (0.05 mol) of labeled and unlabeled D-glucose combined with glycine (0.1 mol) were dissolved in 100 mL of deionized water. The pH of the sample solution was adjusted to 10.0 by adding sodium hydroxide.
+ Open protocol
+ Expand
9

Metabolic Tracing of Cell Reprogramming

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells from each experimental group were plated in three wells of 6-well plates and analyzed independently as follows. The culture medium from cells undergoing reprogramming at 10 dpi was replaced with DMEM without glucose (Nacalai Tesque) supplemented with 4.5 g/L D-glucose-13C6 (Sigma-Aldrich), followed by incubation with 5% CO2 for 1 h at 37 °C. Then, the medium was aspirated, and the cells were washed in ice-cold PBS three times with chilling, followed by snap freezing in liquid nitrogen. The plates were stored at − 80 °C until metabolite extraction. The methods used for metabolite extraction and cytosolic fractionation to remove mitochondria from cell lysates have been described previously [22 , 23 (link)]. See Additional file 5 for further details.
+ Open protocol
+ Expand
10

Metabolomic Analysis of MEF Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MEFs were exposed to torin1 (475991, Merk Millipore, Burlington, MA, USA) and staurosporine (81590, Cayman Chemical, Ann Arbor, MI, USA), which had been pre-dissolved in dimethylsulfoxide (DMSO). MEF cells were seeded in Permanox 1-well Lab-Tek chamber slides from Nunc, Thermo Scientific (Rochester, New York, NY, USA) in Dulbecco’s Modified Eagle Medium (DMEM) (Life Technologies, Carlsbad, CA, USA) supplemented with 10% Fetal Bovine Serum (FBS) and 1% Penicillin-Streptomycin (Life Technologies, Carlsbad, CA, USA). Internal standards (IS) for hippuric acid-(phenyl-13C6), L-lysine-13C615N2, leucine-5,5,5-D3, D-glucose-13C6, glyceryl tri-(palmitate-1-13C), and cholic acid-2,2,4,4-D4 were purchased from Sigma-Aldrich (St. Louis, MI, USA). Caffeine-13C3 was acquired from Cerilliant Corporation (Round Rock, TX, USA), 18:1-D7 lyso-phosphatidylethanolamine (LPE), 18:1-D7 lyso-phosphatidylcholine (LPC) from Avanti Polar Lipids (Birmingham, UK), octanoyl-L-carnitine-(N-methyl-D3), ceramide [d18:1/18:1-(9Z)-13C18] and L-phenylalanine-13C915N from Cambridge Isotope Laboratories (Andover, MA, USA). Additional materials and chemicals are described in Supplementary Materials Section S1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!